Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
intermediate care facility (ICF)
Internet pharmacies, regulation of
Internet prescriptions dispensing regulations Section 502(b)(2) rules validity of
interns, regulation of
interstate commerce
Interstate Commerce Clause Constitution State Authority to Regulate State vs Federal Authority
In the Case of Daniel Family Pharmacy (1999) Daniel Family Pharmacy Dispensing of Schedule III, IV, and V Controlled Substances
In the Matter of CVS Pharmacy Wayne (1989) In the Matter of CVS Pharmacy Wayne State Advertising Laws: The Virginia Case and the First Amendment
In the Matter of Sobel v. Board of Pharmacy (1994)
In the Matter of the Application of W.D.P. (2004)
inventory records, recordkeeping
investigational drugs access to access to - united states V. rutherford expedited approval of drugs individual patient access to Individual Patient Access to Investigational Drugs for Serious Diseases (Parallel Track Policy) (§ 561) widespread patient treatment with
Investigational New Drug (IND) application Pharmacy Compounding vs Manufacturing
invoices
See institutional review board (IRB) See institutional review board (IRB) The Road to an Approved New Drug Application
Izzo v. Manhattan Medical Group (1990)
About
21st Century Cures Act
See actual acquisition cost (AAC) Medicaid Overview of Important Developments in Medicaid and Prescription Drug Reimbursement Prescription Drug Coverage See actual acquisition cost (AAC)
Abbott Laboratories v. Portland Retail Druggists Association, Inc. (1976)
abbreviated new drug application (ANDA) controversies creation of Drug Price Competition and Patent Term Restoration Act of 1984 generic substitutions Pfizer v. Shalala (1998) - Pfizer, Inc. v. Shalala section 505(b)(2) United States v. Hiland United States v. Hiland - United States v. Hiland
Abigail Alliance for Better Access to Developmental Drugs and Washington Legal Foundation v. Eschenbach (2006)
abuse, Medicare and Medicaid
accounting for disclosures, HIPAA
acknowledgment of notice, HIPAA
See American Council on Pharmaceutical Education (ACPE) Continuing Education Licensing of Pharmacists See American Council on Pharmaceutical Education (ACPE)
acquisition cost
active ingredients Drug Price Competition and Patent Term Restoration Act (PTRA) of 1984 misbranding nonprescription drug labeling prescription drug labeling
actual acquisition cost (AAC)
actual damages